Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Apnimed, Inc.
APMD · SEC Filings
website
81
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel ora...
Price
15.81
Market Cap
629.6 M
Float
11.69 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about APMD
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Apnimed, Inc.
APMD · SEC Filings
11.69 M
Float
15.81
Price
629.6 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 8, 2026
News
TYPE
HEADLINE
FILED AT
8-K
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update on AD109 (Oxnimbi)
Sep 8, 2026
8-K
Apnimed, Inc. Files Amended Certificate of Incorporation and Bylaws in Connection with IPO
Aug 3, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B4
Form 424B4 - Prospectus [Rule 424(b)(4)]
Jul 31, 2026
Registrations
TYPE
HEADLINE
FILED AT
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G
SHIONOGI & CO LTD (Filed by)
Nov 4, 2026
SCHEDULE 13G
AMERIPRISE FINANCIAL INC (Filed by)
Aug 7, 2026
SCHEDULE 13G
Tao Capital Management LP (Filed by)
Aug 6, 2026
4
Morningside Venture Investments Ltd (Reporting)
Aug 5, 2026
4
Alpha Wave Global, LP (Reporting)
Aug 5, 2026
4
Lind Kevin Robert (Reporting)
Aug 3, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Jul 31, 2026
